BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 3036671)

  • 1. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
    Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
    Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 8. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
    Than GN; Bohn H; Csaba IF; Szabó DG; Karg NJ; Göcze P
    Arch Gynecol; 1981; 231(1):33-9. PubMed ID: 6174083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
    Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
    Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB; Lehr M; Lewis JL
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract]   [Full Text] [Related]  

  • 17. Concanavalin A binding of pregnancy-specific beta-1-glycoprotein in normal pregnancy and trophoblastic disease.
    Koistinen R; Heikinheimo M; Rutanen EM; Stenman UH; Lee JN; Seppälä M
    Oncodev Biol Med; 1981; 2(3):179-82. PubMed ID: 6272237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK; Daunter B
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumors.
    Mehta AR; Shahani SK
    Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):67-9. PubMed ID: 2823620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prolactin levels and immunohistochemical localization of prolactin in trophoblastic disease.
    Ranta T; Wahlström T; Rutanen EM; Stenman UH; Seppälä M
    Acta Pathol Microbiol Scand A; 1981 May; 89(3):235-9. PubMed ID: 6274140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.